Limited Metastatic Pancreatic Cancer clinical trials

Explore recruiting limited metastatic pancreatic cancer clinical trials.

Also recruiting in Europe

Limited Metastatic Pancreatic Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Safety and efficacy of IMM-101 combined with stereotactic radiotherapy in patients with limited metastatic pancreatic cancer (MEPANC-1)

Netherlands

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Limited Metastatic Pancreatic Cancer trials by city

Limited Metastatic Pancreatic Cancer in Toronto Limited Metastatic Pancreatic Cancer in Vancouver Limited Metastatic Pancreatic Cancer in Montreal Limited Metastatic Pancreatic Cancer in Calgary Limited Metastatic Pancreatic Cancer in Edmonton Limited Metastatic Pancreatic Cancer in Ottawa Limited Metastatic Pancreatic Cancer in Winnipeg Limited Metastatic Pancreatic Cancer in Quebec City Limited Metastatic Pancreatic Cancer in Hamilton Limited Metastatic Pancreatic Cancer in Kitchener Limited Metastatic Pancreatic Cancer in London Limited Metastatic Pancreatic Cancer in Halifax Limited Metastatic Pancreatic Cancer in New York Limited Metastatic Pancreatic Cancer in Los Angeles Limited Metastatic Pancreatic Cancer in Chicago Limited Metastatic Pancreatic Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease